Following the administration of P140, there is a significant decrease of activated cells that are over-represented in the spleen and peripheral blood and a decrease level of pro-inflammatory IL-17a in the serum of treated MRL/lpr mice, a cytokine involved in the pathogenesis of SLE (13). This evidence concerns the gene IL17A and systemic lupus erythematosus.